Global Expansion Shield Therapeutics has commercialized its iron deficiency products in various regions including the US, UK, European Union, Australia, New Zealand, China, Hong Kong, Macau, Taiwan, South Korea, and Canada. Sales teams could explore further market penetration opportunities in these regions.

Strategic Partnerships Shield Therapeutics has established exclusive license agreements with pharmaceutical companies in different countries. Leveraging these partnerships, sales professionals could identify collaboration opportunities to expand market reach and increase product sales.

Financial Investment The recent investment of $20 million from SWK Holdings Corporation indicates financial stability and growth potential. Sales development representatives could use this strong financial position as a selling point to attract potential investors or partners.

Top Talent Acquisition Shield Therapeutics has appointed key executives like Santosh Shanbhag as the Chief Financial Officer and Andy Hurley as the Chief Commercial Officer. Sales teams could leverage the expertise of these experienced professionals to drive business growth and enhance sales strategies.

Competitive Analysis By studying similar companies like AOP Orphan Pharmaceuticals AG, Theratechnologies, AstraZeneca, and Akebia Therapeutics, sales professionals can gain insights into market trends, competitive positioning, and potential areas for differentiation to strengthen Shield Therapeutics' sales approach.